CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Hanmi Science Co Ltd (Parent) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Hanmi Science Co Ltd (Parent)
Paltan Industrial Complex
214, Muha-ro, Paltan-myeon
Phone: +82 24109114p:+82 24109114 HWASEONG, 18536  South Korea Fax: +82 24109022f:+82 24109022
Business Summary
Hanmi Science Co Ltd is a Korean-based holding company principally involved in the management of subsidiaries. Through subsidiaries in Japan, Europe and Korea, the Company operates in three segments. The Pharmaceutical Products Wholesale segment mainly engages in the distribution of pharmaceutical products. The Holding Business segment mainly engages in the business of controlling subsidiaries. The Other segment mainly engage in the production and sales of pharmaceuticals, and the supply of quasi-drugs and health functional foods, beverages and functional cosmetics.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202112/31/2021Yes----

Industries
SIC Code Description
5122 Drugs, drug proprietaries, and druggists' sundries
2834 Pharmaceutical preparations
5812 Eating places
5141 Groceries, general line
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman, Chief Executive Officer Yeong SukSong 74 3/24/2022 9/28/2020
Co-President Jong HunYim 45 1/1/2022 1/1/2009
Co-President Jong YunYim 50 3/24/2022 3/13/2009
6 additional Officers and Directors records available in full report.

Business Names
Business Name
Hanmi Pharmaceutical Co., Ltd. (Parent)
Hanmi Science Co.,Ltd.

General Information
Number of Employees: 82 (As of 9/30/2013)
Outstanding Shares: 67,982,565 (As of 3/31/2023)
Shareholders: 9,091
Fax Number: +82 24109022


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, September 27, 2023